Sodium chloride/dextran 70

Drug Profile

Sodium chloride/dextran 70

Alternative Names: Hypertonic saline dextran; RescueFlow; Sodium chloride/dextran

Latest Information Update: 21 Dec 2016

Price : $50

At a glance

  • Originator Nonindustrial source
  • Developer Karo Pharma AB; Medisan Pharmaceuticals AB; Nonindustrial source
  • Class Electrolytes
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Hypovolaemia

Most Recent Events

  • 07 Jun 2011 BioPhausia has been acquired by Medivir AB
  • 15 May 2007 Launched for Hypovolaemia in France (IV)
  • 15 May 2004 Launched for Hypovolaemia in Israel (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top